PNC Financial Services Group
CLVS

PNC Financial Services Group’s Clovis Oncology, Inc. CLVS Stock Holding History

PNC Financial Services Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-225
Closed – – 4899
2022
Q3 		$0 Hold
225
– – ﹤0.01% 4694
2022
Q2 		$0 Hold
225
– – ﹤0.01% 4833
2022
Q1 		$0 Sell
225
-2,688
-92% -$5.28K ﹤0.01% 4787
2021
Q4 		$8K Buy
2,913
+2,688
+1,195% +$9.94K ﹤0.01% 3863
2021
Q3 		$1K Sell
225
-5,775
-96% -$27.8K ﹤0.01% 4242
2021
Q2 		$35K Hold
6,000
– – ﹤0.01% 3249
2021
Q1 		$43K Sell
6,000
-1,000
-14% -$6.71K ﹤0.01% 3070
2020
Q4 		$34K Buy
7,000
+2,000
+40% +$10.1K ﹤0.01% 3130
2020
Q3 		$29K Hold
5,000
– – ﹤0.01% 3048
2020
Q2 		$34K Hold
5,000
– – ﹤0.01% 2977
2020
Q1 		$32K Hold
5,000
– – ﹤0.01% 2884
2019
Q4 		$52K Hold
5,000
– – ﹤0.01% 2879
2019
Q3 		$20K Buy
5,000
+3,000
+150% +$24.3K ﹤0.01% 3362
2019
Q2 		$30K Hold
2,000
– – ﹤0.01% 3193
2019
Q1 		$50K Hold
2,000
– – ﹤0.01% 2949
2018
Q4 		$36K Sell
2,000
-2,220
-53% -$45.4K ﹤0.01% 3047
2018
Q3 		$124K Sell
4,220
-3,263
-44% -$126K ﹤0.01% 2470
2018
Q2 		$339K Buy
7,483
+2,056
+38% +$100K ﹤0.01% 1883
2018
Q1 		$287K Sell
5,427
-48,871
-90% -$2.85M ﹤0.01% 1956
2017
Q4 		$3.69M Buy
54,298
+50,238
+1,237% +$3.51M ﹤0.01% 839
2017
Q3 		$334K Buy
4,060
+1,240
+44% +$98.3K ﹤0.01% 1857
2017
Q2 		$265K Buy
2,820
+20
+0.7% +$1.22K ﹤0.01% 1978
2017
Q1 		$179K Buy
2,800
+100
+4% +$6.08K ﹤0.01% 2193
2016
Q4 		$121K Buy
2,700
+1,100
+69% +$38.7K ﹤0.01% 2369
2016
Q3 		$58K Sell
1,600
-8
-0.5% -$172 ﹤0.01% 2763
2016
Q2 		$22K Sell
1,608
-2,020
-56% -$29.5K ﹤0.01% 3230
2016
Q1 		$69K Buy
3,628
+3,485
+2,437% +$73.8K ﹤0.01% 2672
2015
Q4 		$5K Sell
143
-912
-86% -$58.8K ﹤0.01% 3893
2015
Q3 		$97K Buy
1,055
+304
+40% +$26.3K ﹤0.01% 2545
2015
Q2 		$65K Buy
751
+247
+49% +$21.1K ﹤0.01% 2878
2015
Q1 		$37K Buy
504
+100
+25% +$7.06K ﹤0.01% 3201
2014
Q4 		$24K Sell
404
-413
-51% -$21.7K ﹤0.01% 3087
2014
Q3 		$38K Sell
817
-2,484
-75% -$104K ﹤0.01% 2815
2014
Q2 		$136K Buy
3,301
+290
+10% +$14.9K ﹤0.01% 2115
2014
Q1 		$208K Buy
+3,011
New +$221K ﹤0.01% 1875
2013
Q3 		– Sell
-250
Closed -$17K – 3674
2013
Q2 		$17K Buy
+250
New +$11.2K ﹤0.01% 2823

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

PNC Financial Services Group's CLVS Position: Q4 2022 in Review

PNC Financial Services Group sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 225 shares.

PNC Financial Services Group first reported a position in CLVS in Q2 2013 and held it in 36 quarters. The position peaked at $3.69M in Q4 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • PNC Financial Services Group reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 225 Clovis Oncology, Inc. shares in Q4 2022.
  • PNC Financial Services Group first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 36 quarters.
  • PNC Financial Services Group's Clovis Oncology, Inc. position peaked at $3.69M in Q4 2017.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on PNC Financial Services Group's 13F filing for Q4 2022, filed 10 Feb 2023.